BioMEMS

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

A&T Corporation (Symbol:6722) SWOT Analysis, Strategy, Revenues and Profits

A&T Corporation (Symbol:6722) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. A&T Corporation SWOT Analysis report provides you a strategic analysis ...

Industries: In Vitro Diagnostic | Countries: South Korea, Japan, Russian Federation, Taiwan, China

BioCurex, Inc. (Symbol:BOCX) SWOT Analysis, Strategy, Revenues and Profits

BioCurex, Inc. (Symbol:BOCX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. BioCurex, Inc. SWOT Analysis report provides you a strategic analysis ...

Industries: In Vitro Diagnostic | Countries: Canada, United States, United Kingdom, China

ESAOTE S.p.A. SWOT Analysis, Strategy, Revenues and Profits

ESAOTE S.p.A. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Medical Imaging | Countries: World, Argentina, Brazil, United States, Spain, Italy, France, Germany, India, China

FEI Company (Symbol:FEIC) SWOT Analysis, Strategy, Revenues and Profits

FEI Company (Symbol:FEIC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. FEI Company SWOT Analysis report provides you a strategic analysis ...

Industries: Medical Imaging | Countries: United States, Czech Republic, Netherlands, Singapore, Japan, China

ContextVision AB (Symbol:COV) SWOT Analysis, Strategy, Revenues and Profits

ContextVision AB (Symbol:COV) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. ContextVision AB SWOT Analysis report provides you a strategic analysis ...

Industries: Medical Imaging | Countries: China, United States, Sweden, Russian Federation, South Korea, Japan

Shanghai Fosun Medical Technology Development Co., Ltd. - Strategic SWOT Analysis Review

Shanghai Fosun Medical Technology Development Co., Ltd. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 15 pages

Summary Shanghai Fosun Medical Technology Development Co., Ltd. (Shanghai Fosun) is a medical device company. The company produces vitro diagnostic (IVD) products. Its product portfolio consists of four product lines such as clinical chemistry reagents, microbiology, molecular diagnostic products, and ...

Industries: In Vitro Diagnostic | Countries: China

China Medical Technologies, Inc. - Strategic SWOT Analysis Review

China Medical Technologies, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 15 pages

Summary China Medical Technologies, (China Medical) is engaged in the development, manufacture and marketing of in-vitro diagnostics (IVD) products for the treatment of solid cancers and benign tumors. The company principally operates through its wholly owned subsidiaries, Beijing Yuande Bio-Medical ...

Industries: In Vitro Diagnostic | Countries: China

Imaging Devices in China

Imaging Devices in China

  • $ 898
  • Industry report
  • by Euromonitor International
  • October 2014
  • 22 pages

Due to the rocketing sales of smartphones and tablets in China, retail volume sales of imaging devices decreased by 9% in 2014. The continued improvement of imaging functions in smartphones and tablets brought mounting threats to imaging devices, with more consumers using their smartphones directly fo ...

Industries: Medical Imaging | Countries: China

Diagnostic Reagent Markets in China

Diagnostic Reagent Markets in China

  • $ 4 000
  • Industry report
  • by Asia Market Information & Development Company
  • October 2014
  • 193 pages

China's demand for Diagnostic Reagent has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consume ...

Industries: In Vitro Diagnostic | Countries: China

Latest Chinese Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration: From Regulations to Practices (2014 Edition)

Latest Chinese Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration: From Regulations to Practices (2014 Edition)

  • $ 1 495
  • Industry report
  • by Access China Management Consulting Ltd.
  • September 2014
  • 208 pages

Synopsis China's regulatory framework for in-vitro diagnostic reagents is undergoing earthshaking changes. It will bring overseas and multinational in-vitro diagnostic reagent manufacturers the maximum challenges and opportunities. How do you in compliance with the latest Chinese regulations on in-vitro ...

Industries: In Vitro Diagnostic | Countries: China

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.